Brendan McAtamney
THE SURPRISE bid by US fund Clayton, Dubilier & Rice (CD&R) for UDG Healthcare may prove timely for investors given the sensitive area in which the Irish company operates. The promotion of presecription medicine is a legal minefield and could well end up being regulated out of existence. The arrival of Paul Singer – the... Read more »
To access this content, you must be a Phoenix subscriber.
Get access to The Phoenix online for as low as €1.50 per week. Read all the regular online only Phoenix stories AND receive the packed digital edition every fortnight (25 per year). Great value for so many inside stories!
